Spectrum Pharmaceutecals Inc (SPPI)

[Tartiaboy]

Fair enough.

My broader point is that small companies such as SPPI can't afford to get too arrogant (JT) and they need to explore any real opportunities they get.

I strongly believe that Qapzola/Apaziquone will be bigger than any of the current six drugs we have. SPPI can shoot for the moon with Poziotinib, but Apaziquone may be a great insurance policy. It alone could double our current revenue stream-IMO.

I bring up Vicinium because it and Apaziquone together could cover most of the NMIBC space and help put a nice floor under SPPI's PPS.

To just license Qapzola out seems to be a waste, unless SPPI has another new late stage drug target to add to the quiver.

I see Apaziquone as a bird in hand.

Let's return to this when we see the Apaziquone phase III read-out, hopefully next year.